SCRIMED helps healthcare leaders turn messy workflows into governed AI pilots buyers can trust.

A fast, finite way to identify where SCRIMED can reduce workflow friction and prepare a buyer-ready pilot decision.

A 45-90 day no-PHI pilot that gives enterprise sponsors proof, governance evidence, workflow metrics, and an expansion decision.

A controlled enterprise activation path for buyers who need protected proof, diligence rooms, onboarding, and production-readiness planning.

Assess SCRIMED as a whole across product, services, revenue, margin, approvals, cybersecurity, AI, health-record safety, launch, investors, limitations, and proof routes.

Track the required tasks still incomplete before live clinical care, PHI, production connectors, regulated claims, customer go-live, and global clinical deployment.

Map demos into recommended pilot packages, price bands, proof assets, market benchmarks, no-PHI intake, and margin-safe hard stops before buyer calls.

Review strict branded-domain gates, sandbox DNS classification, fallback boundaries, product/service launch tracks, and hard stops.

Inspect product offers, workflow demos, AgentOS, proof routes, and governed pilot boundaries.

Turn packaged offers into scoped work orders, acceptance criteria, delivery artifacts, buyer handoffs, and retained authority gates.

Review public competitor patterns translated into SCRIMED-specific build paths, proof metrics, API posture, payer workflows, and no-copy guardrails.

Review competitor threat profiles, weakness relief, claims-safe counter-positioning, privacy gates, cybersecurity controls, and infiltration-deterrence hard stops.

Review page inventory, API route count, route groups, smoke coverage, protected fail-closed checks, and retained AAL2 boundaries.

Review product/service controls, fault classes, efficiency improvements, owners, proof routes, and retained approval boundaries.

Review capacity planning, tenant scale, queueing, SLO readiness, incidents, support load, global deployment, and usage-cost controls.

Review API contracts, operator UI paths, AI model-route readiness, agent approvals, eval loops, evidence retrieval, and cost controls.

Resolve cross-system gaps, inefficiencies, bottlenecks, hard stops, proof-route gaps, and margin/control drag through owned sprints.

Turn blocked requests into safe workaround packets, escalation owners, proof routes, expiration rules, and graduation gates.

Review weakness relief, competitive edge, sellable value, and audience packets for angels, strategics, private investors, faith-based clinics, and partners.

Prioritize buyer segments, sellable offers, conversion lanes, revenue proof steps, bottlenecks, owners, and proof routes.

Review revenue capabilities, margin controls, legal/accounting/tax roles, deal desk, contract authority, billing readiness, operating cadences, and blocked enterprise claims.

Review claims controls, privacy posture, protected workspaces, auditability, and diligence gates.

Review retained gates for live care, PHI processing, legal approval, regional approval, reimbursement, security certification, and production clinical authorization.

Review HIPAA/BAA, FDA CDS/SaMD, SOC 2, HITRUST, ISO, EU AI Act, GDPR, NHS DTAC, MHRA, Australia Essential Eight, regional packs, and blocked certification claims.

Review 24/7 agent-assisted accuracy checks, evidence attribution, claims guard, security drift, QA regression, incident learning, and internal-only future research.

Review metadata-only routing for questionnaires, SOC and pentest evidence, legal artifacts, vendor-risk, implementation, and buyer diligence without storing sensitive artifacts.

Review region focus, buyer localization packs, partner channels, procurement questions, and retained legal/privacy/clinical gates.

Review investor/audience packets, capital vitality, KPI discipline, unit economics, moat proof, customer proof, and investor narrative without securities, solicitation, or valuation claims.

Move from buyer proof to pricing, protected evidence, activation gates, and pilot execution path.